NextPlat (NXPL) Payables (2010 - 2026)
NextPlat's (NXPL) quarterly Payables came in at $10.4 million in Q2 2026, up 92.43% year-over-year from $5.4 million in Q2 2025, and up 20.66% quarter-over-quarter from $8.7 million in Q1 2026.
Analysis
NextPlat (NXPL) Payables (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Payables for 17 consecutive years, with $10.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Payables rose 92.43% year-over-year to $10.4 million in Q2 2026; TTM through Jun 2026 was $10.4 million, a 92.43% increase from a year earlier, with the FY2025 full-year figure at $8.7 million, up 14.07% from the prior year.
- Payables was $10.4 million for Q2 2026 at NextPlat, up from $8.7 million in the prior quarter.
- Over five years, Payables peaked at $15.1 million in Q1 2024 and troughed at $1.1 million in Q3 2022.
- A 5-year average of $7.1 million and a median of $7.7 million in 2024 frame the typical range for Payables.
- Across the five-year window, Payables soared 1130.84% in 2023 and slumped 55.15% in 2025, its largest moves.
- Over 5 years, Payables stood at $1.6 million in 2022, then soared by 752.05% to $13.5 million in 2023, then tumbled by 43.58% to $7.6 million in 2024, then climbed by 14.07% to $8.7 million in 2025, then advanced by 20.27% to $10.4 million in 2026.
- The last three Payables figures came in at $10.4 million (Q2 2026), $8.7 million (Q1 2026), and $8.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 2.72 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 1.73 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 449.39 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 721.21 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 593.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 73.83 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 171.84 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 251.37 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 5.52 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 10.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.44 Mn |
| Mar 31, 2026 | 8.65 Mn |
| Dec 31, 2025 | 8.68 Mn |
| Sep 30, 2025 | 6.69 Mn |
| Jun 30, 2025 | 5.43 Mn |
| Mar 31, 2025 | 7.80 Mn |
| Dec 31, 2024 | 7.61 Mn |
| Sep 30, 2024 | 8.99 Mn |
| Jun 30, 2024 | 12.10 Mn |
| Mar 31, 2024 | 15.13 Mn |
| Dec 31, 2023 | 13.49 Mn |
| Sep 30, 2023 | 14.07 Mn |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | 1.86 Mn |
| Dec 31, 2022 | 1.58 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.15 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 951,319.00 |